- Home
- APLM vs INHD Comparison
APLM vs INHD Comparison
Compare APLM & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- INHD
- Stock Information
- Founded
- APLM 2016
- INHD 2019
- Country
- APLM United States
- INHD United States
- Employees
- APLM N/A
- INHD N/A
- Industry
- APLM Blank Checks
- INHD
- Sector
- APLM Finance
- INHD
- Exchange
- APLM Nasdaq
- INHD Nasdaq
- Market Cap
- APLM 12.3M
- INHD 12.8M
- IPO Year
- APLM N/A
- INHD 2023
- Fundamental
- Price
- APLM $9.56
- INHD $5.14
- Analyst Decision
- APLM Strong Buy
- INHD
- Analyst Count
- APLM 2
- INHD 0
- Target Price
- APLM $425.00
- INHD N/A
- AVG Volume (30 Days)
- APLM 36.2K
- INHD 15.6K
- Earning Date
- APLM 02-15-2025
- INHD 02-14-2025
- Dividend Yield
- APLM N/A
- INHD N/A
- EPS Growth
- APLM N/A
- INHD N/A
- EPS
- APLM N/A
- INHD N/A
- Revenue
- APLM $2,101,000.00
- INHD $885,495.00
- Revenue This Year
- APLM N/A
- INHD N/A
- Revenue Next Year
- APLM N/A
- INHD N/A
- P/E Ratio
- APLM N/A
- INHD N/A
- Revenue Growth
- APLM 70.54
- INHD 10.72
- 52 Week Low
- APLM $6.50
- INHD $3.00
- 52 Week High
- APLM $91.00
- INHD $13.20
- Technical
- Relative Strength Index (RSI)
- APLM 46.48
- INHD 54.62
- Support Level
- APLM $9.50
- INHD $5.07
- Resistance Level
- APLM $10.67
- INHD $5.60
- Average True Range (ATR)
- APLM 0.92
- INHD 0.20
- MACD
- APLM -0.04
- INHD 0.03
- Stochastic Oscillator
- APLM 13.17
- INHD 53.54
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.